2023
DOI: 10.3390/jpm13030530
|View full text |Cite
|
Sign up to set email alerts
|

The Prognostic Significance of FOXD1 Expression in Head and Neck Squamous Cell Carcinoma

Abstract: It has been reported that forkhead box D1 (FOXD1) plays an established role in human early embryonic development and is broadly involved in various malignancies. However, there is limited information regarding FOXD1 expression in head and neck squamous cell carcinoma (HNSCC). This present study aimed to explore the clinical significance of FOXD1 in patients with HNSCC. Tissue microarrays of 334 primary HNSCC patients who underwent surgery between 2008 and 2010 at Sun Yat-sen University Cancer Center were inves… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 37 publications
0
1
0
Order By: Relevance
“…In our previous study, the improvement in the accuracy of prognostic modeling with the addition of the assessment of PD-L1 expression levels was significant (C-index increased by 0.204) [9]. Another study by us showed that the expression of FOXD1 could serve as an independent prognosticator for head and neck squamous cell carcinoma, which indicated that adding the expression of FOXD1 into the prognostic assessment tool, such as TNM system, could improve the prognostic prediction [31]. A report by Liu et al found that CAV1 promoted glioma progression, and its high expression was related to the poor prognosis [32].…”
Section: Discussionmentioning
confidence: 90%
“…In our previous study, the improvement in the accuracy of prognostic modeling with the addition of the assessment of PD-L1 expression levels was significant (C-index increased by 0.204) [9]. Another study by us showed that the expression of FOXD1 could serve as an independent prognosticator for head and neck squamous cell carcinoma, which indicated that adding the expression of FOXD1 into the prognostic assessment tool, such as TNM system, could improve the prognostic prediction [31]. A report by Liu et al found that CAV1 promoted glioma progression, and its high expression was related to the poor prognosis [32].…”
Section: Discussionmentioning
confidence: 90%